---
title: "Pharmaron Beijing files HKEX next-day disclosure return reporting 5,396,470 new H shares issued"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293443950.md"
description: "Pharmaron Beijing filed a next-day disclosure with the HKEX on July 22, reporting the issuance of 5,396,470 new H shares moved from treasury to a trustee. Consequently, issued H shares excluding treasury increased by 1.53% to 358,111,057, while treasury shares decreased to 1,866,830. The total number of shares remained unchanged at 359,977,887."
datetime: "2026-07-22T08:40:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293443950.md)
  - [en](https://longbridge.com/en/news/293443950.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293443950.md)
generator: "portal-rs"
---

# Pharmaron Beijing files HKEX next-day disclosure return reporting 5,396,470 new H shares issued

-   Pharmaron Beijing filed a next-day disclosure return showing 5,396,470 H shares moved from treasury to a trustee on July 22. \* Issued H shares excluding treasury rose 1.53% to 358,111,057; treasury shares fell to 1,866,830; total shares stayed 359,977,887. \* Total new or converted shares: 0. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmaron Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260722-12252336), on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)

## Related News & Research

- [Morgan Stanley Reaffirms Their Buy Rating on Pharmaron Beijing Co., Ltd. Class H (17Q1)](https://longbridge.com/en/news/299378197.md)
- [UBS Reaffirms Their Buy Rating on Akeso, Inc. (9926)](https://longbridge.com/en/news/298999486.md)
- [Jensen Huang Says AI CEOs May Have 'Ulterior', Maybe 'Political' Reasons For AI Doomsday Warnings: 'Go and Read Between The Lines'](https://longbridge.com/en/news/299637656.md)
- [Michael Saylor Says, 'A Little More Orange': Will Strategy Report BTC Purchases After Hitting Pause for 3 Weeks?](https://longbridge.com/en/news/299601303.md)
- [Prediction: Berkshire Hathaway's Operating Earnings Will Top $48 Billion in 2026](https://longbridge.com/en/news/299668979.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**